Gyre Therapeutics, Inc. (GYRE)
USD 7.24
(-4.99%)
USD 7.24
(-4.99%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 108.81 Million USD | 2720450.0% |
| 2022 | -4000.00 USD | 90.48% |
| 2021 | -42 Thousand USD | -100.36% |
| 2020 | 11.78 Million USD | 126.87% |
| 2019 | -43.85 Million USD | -104.3% |
| 2018 | -21.46 Million USD | -81.49% |
| 2017 | -11.82 Million USD | -16.47% |
| 2016 | -10.15 Million USD | -141.35% |
| 2015 | -4.2 Million USD | 15.71% |
| 2014 | -4.99 Million USD | -70.49% |
| 2013 | -2.92 Million USD | -105.06% |
| 2012 | 57.86 Million USD | -40.74% |
| 2011 | 97.63 Million USD | 13.91% |
| 2010 | 85.71 Million USD | 251.7% |
| 2009 | 24.37 Million USD | 26.04% |
| 2008 | 19.33 Million USD | 78.04% |
| 2007 | 10.86 Million USD | -59.9% |
| 2006 | 27.08 Million USD | 3774.24% |
| 2005 | 698.98 Thousand USD | -80.25% |
| 2004 | 3.53 Million USD | 106.41% |
| 2003 | 1.71 Million USD | -16.01% |
| 2002 | 2.04 Million USD | 19.91% |
| 2001 | 1.7 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 26.19 Million USD | -8.84% |
| 2024 Q2 | 24.45 Million USD | -6.64% |
| 2023 Q4 | 28.73 Million USD | -2.46% |
| 2023 FY | 108.81 Million USD | 2720450.0% |
| 2023 Q1 | 23.84 Million USD | 1598.07% |
| 2023 Q2 | 25.81 Million USD | 8.25% |
| 2023 Q3 | 29.45 Million USD | 14.1% |
| 2022 FY | -4000.00 USD | 90.48% |
| 2022 Q3 | 28.36 Million USD | 21.92% |
| 2022 Q1 | -4000.00 USD | 71.43% |
| 2022 Q2 | 23.26 Million USD | 581752.73% |
| 2022 Q4 | -1.59 Million USD | -105.61% |
| 2021 FY | -42 Thousand USD | -100.36% |
| 2021 Q1 | -13 Thousand USD | 0.0% |
| 2021 Q3 | -8000.00 USD | -14.29% |
| 2021 Q2 | -7000.00 USD | 46.15% |
| 2021 Q4 | -14 Thousand USD | -75.0% |
| 2020 FY | 11.78 Million USD | 126.87% |
| 2020 Q2 | -84 Thousand USD | -100.71% |
| 2020 Q1 | 11.88 Million USD | 210.14% |
| 2020 Q3 | -18 Thousand USD | 78.57% |
| 2020 Q4 | - USD | 100.0% |
| 2019 Q3 | -9.92 Million USD | 10.66% |
| 2019 Q1 | -12.02 Million USD | -45.87% |
| 2019 FY | -43.85 Million USD | -104.3% |
| 2019 Q2 | -11.11 Million USD | 7.62% |
| 2019 Q4 | -10.79 Million USD | -8.72% |
| 2018 Q2 | -3.88 Million USD | -3.29% |
| 2018 FY | -21.46 Million USD | -81.49% |
| 2018 Q1 | -3.76 Million USD | -16.1% |
| 2018 Q3 | -5.57 Million USD | -43.35% |
| 2018 Q4 | -8.24 Million USD | -47.89% |
| 2017 Q2 | -3.29 Million USD | -83.8% |
| 2017 Q4 | -3.24 Million USD | 7.0% |
| 2017 FY | -11.82 Million USD | -16.47% |
| 2017 Q1 | -1.79 Million USD | 12.3% |
| 2017 Q3 | -3.48 Million USD | -5.99% |
| 2016 Q2 | -2.64 Million USD | -21.41% |
| 2016 FY | -10.15 Million USD | -141.35% |
| 2016 Q3 | -3.28 Million USD | -24.37% |
| 2016 Q4 | -2.04 Million USD | 37.91% |
| 2016 Q1 | -2.17 Million USD | -31.38% |
| 2015 FY | -4.2 Million USD | 15.71% |
| 2015 Q4 | -1.65 Million USD | -20.33% |
| 2015 Q3 | -1.37 Million USD | -197.41% |
| 2015 Q2 | -463 Thousand USD | 65.0% |
| 2015 Q1 | -1.32 Million USD | -4.26% |
| 2014 Q4 | -1.26 Million USD | 3.2% |
| 2014 FY | -4.99 Million USD | -70.49% |
| 2014 Q1 | -1.16 Million USD | -1348.35% |
| 2014 Q2 | -1.25 Million USD | -7.76% |
| 2014 Q3 | -1.31 Million USD | -4.8% |
| 2013 Q3 | - USD | 0.0% |
| 2013 FY | -2.92 Million USD | -105.06% |
| 2013 Q2 | - USD | -100.0% |
| 2013 Q1 | 3.53 Million USD | 499.32% |
| 2013 Q4 | 93 Thousand USD | 0.0% |
| 2012 Q4 | 590 Thousand USD | -23.18% |
| 2012 FY | 57.86 Million USD | -40.74% |
| 2012 Q1 | 22.85 Million USD | 20.65% |
| 2012 Q2 | 33.64 Million USD | 47.2% |
| 2012 Q3 | 768 Thousand USD | -97.72% |
| 2011 Q2 | 20.74 Million USD | -46.8% |
| 2011 Q4 | 18.94 Million USD | -0.05% |
| 2011 Q3 | 18.95 Million USD | -8.62% |
| 2011 FY | 97.63 Million USD | 13.91% |
| 2011 Q1 | 38.99 Million USD | 65.97% |
| 2010 Q4 | 23.49 Million USD | 7.79% |
| 2010 FY | 85.71 Million USD | 251.7% |
| 2010 Q3 | 21.79 Million USD | 4.29% |
| 2010 Q2 | 20.9 Million USD | 7.09% |
| 2010 Q1 | 19.51 Million USD | 251.04% |
| 2009 Q2 | 2.57 Million USD | -56.5% |
| 2009 Q1 | 5.91 Million USD | -6.64% |
| 2009 Q3 | 12.45 Million USD | 384.33% |
| 2009 Q4 | -12.92 Million USD | -203.73% |
| 2009 FY | 24.37 Million USD | 26.04% |
| 2008 Q3 | 3.95 Million USD | -20.62% |
| 2008 Q2 | 4.97 Million USD | 22.24% |
| 2008 FY | 19.33 Million USD | 78.04% |
| 2008 Q1 | 4.07 Million USD | 20.32% |
| 2008 Q4 | 6.33 Million USD | 60.27% |
| 2007 Q1 | 1.88 Million USD | -92.51% |
| 2007 Q4 | 3.38 Million USD | 14.62% |
| 2007 FY | 10.86 Million USD | -59.9% |
| 2007 Q3 | 2.95 Million USD | 11.99% |
| 2007 Q2 | 2.63 Million USD | 39.84% |
| 2006 Q2 | 611.73 Thousand USD | 47.34% |
| 2006 FY | 27.08 Million USD | 3774.24% |
| 2006 Q4 | 25.18 Million USD | 2807.29% |
| 2006 Q3 | 866.34 Thousand USD | 41.62% |
| 2006 Q1 | 415.17 Thousand USD | 25575.76% |
| 2005 Q4 | 1617.00 USD | -99.25% |
| 2005 Q2 | 201.86 Thousand USD | -28.07% |
| 2005 FY | 698.98 Thousand USD | -80.25% |
| 2005 Q3 | 214.84 Thousand USD | 6.43% |
| 2005 Q1 | 280.65 Thousand USD | 0.0% |
| 2004 FY | 3.53 Million USD | 106.41% |
| 2003 FY | 1.71 Million USD | -16.01% |
| 2002 FY | 2.04 Million USD | 19.91% |
| 2001 FY | 1.7 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | 120.47 Million USD | 9.678% |
| Jaguar Health, Inc. | 7.72 Million USD | -1308.778% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 16487.651% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 2176380.0% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 92.831% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 9.135% |
| ContextLogic Inc. | 59 Million USD | -84.431% |
| MiMedx Group, Inc. | 266.84 Million USD | 59.222% |
| MEI Pharma, Inc. | 49.32 Million USD | -120.597% |
| AlloVir, Inc. | -398 Thousand USD | 27440.201% |
| Novavax, Inc. | 639.93 Million USD | 82.996% |
| Aptorum Group Limited | -1.11 Million USD | 9861.835% |
| Ardelyx, Inc. | 106.66 Million USD | -2.019% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 54.799% |
| Psyence Biomedical Ltd. | -240.00 USD | 45339266.667% |
| Vaxcyte, Inc. | -75 Million USD | 245.085% |
| Precigen, Inc. | 106 Thousand USD | -102554.717% |
| Pharming Group N.V. | 220.1 Million USD | 50.562% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -21028.932% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -10684.341% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 0.873% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 159.983% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 21157.541% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bicycle Therapeutics plc | -129.52 Million USD | 184.013% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 340.075% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 594.902% |
| Acelyrin, Inc. | -115 Thousand USD | 94720.87% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 19156.743% |
| Senti Biosciences, Inc. | -2.68 Million USD | 4155.684% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -2586.102% |
| AbCellera Biologics Inc. | 38.02 Million USD | -186.164% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 2367.903% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -90578.333% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -273.559% |
| Chimerix, Inc. | 324 Thousand USD | -33484.568% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -21838.306% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 132800.0% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 449.125% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 22216.667% |
| Elevation Oncology, Inc. | -39 Thousand USD | 279110.256% |
| Alkermes plc | 1.37 Billion USD | 92.084% |
| Fortress Biotech, Inc. | 57.85 Million USD | -88.087% |
| Fortress Biotech, Inc. | 57.85 Million USD | -88.087% |
| Agenus Inc. | 139.61 Million USD | 22.061% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -556.416% |
| Dyadic International, Inc. | 922.95 Thousand USD | -11689.715% |
| ImmuCell Corporation | 4.39 Million USD | -2375.136% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -416.661% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 202.536% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 62335.262% |
| Immix Biopharma, Inc. | -5468.00 USD | 1990114.631% |
| Incyte Corporation | 3.44 Billion USD | 96.837% |
| IO Biotech, Inc. | -756 Thousand USD | 14493.386% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 332.315% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 914.607% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 246352.376% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 210.789% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 197943.636% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -13467.83% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 20747.818% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -270.279% |
| NextCure, Inc. | -3.68 Million USD | 3053.692% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -471.412% |
| Onconetix, Inc. | -1.12 Million USD | 9753.777% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 475.635% |
| Opthea Limited | 21.72 Thousand USD | -500885.267% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 189916.139% |
| PureTech Health plc | -1.6 Million USD | 6888.147% |
| Pyxis Oncology, Inc. | -2 Million USD | 5540.7% |
| Seer, Inc. | 7.02 Million USD | -1448.513% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 1082718.645% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -1282.467% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 2860.342% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -25563.679% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -4.529% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 19.557% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 212.237% |
| ChromaDex Corporation | 50.78 Million USD | -114.285% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 47002.586% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 240.228% |
| CRISPR Therapeutics AG | 240.95 Million USD | 54.841% |
| Precision BioSciences, Inc. | 40.47 Million USD | -168.862% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 210.85% |
| Innoviva, Inc. | 261.06 Million USD | 58.319% |
| Summit Therapeutics Inc. | -2.05 Million USD | 5408.0% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -2385.473% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -405.055% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 91933.135% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 76033.873% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -17767.652% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 65.31% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -4127.428% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 214554.08% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 1633.023% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 23030.175% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 1046388.462% |
| Soligenix, Inc. | 97.31 Thousand USD | -111720.863% |
| Century Therapeutics, Inc. | -10.8 Million USD | 1106.698% |
| Kura Oncology, Inc. | -849 Thousand USD | 12916.726% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 262.157% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 74123.129% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -9.87% |
| Autolus Therapeutics plc | -4.86 Million USD | 2335.751% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -162.925% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 64870.238% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -14.876% |
| GRI Bio, Inc. | 10.84 Million USD | -903.727% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -4184.039% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 1352.607% |
| IGM Biosciences, Inc. | -211.66 Million USD | 151.41% |
| INmune Bio, Inc. | 155 Thousand USD | -70102.581% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -75.679% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 7323.969% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 16880.527% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 371808.683% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -26968.159% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 5551.603% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 34864.856% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -15.195% |
| Verastem, Inc. | -62 Thousand USD | 175606.452% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -4368.747% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 41791.188% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -3494.78% |
| Histogen Inc. | 3.76 Million USD | -2787.079% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -18785.451% |
| Surrozen, Inc. | -27.23 Million USD | 499.611% |
| Organovo Holdings, Inc. | -5.38 Million USD | 2119.187% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 9131.107% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 524.276% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -442.659% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 5495756.566% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -1693.709% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 162192.029% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 29.703% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -74532.373% |
| Apollomics, Inc. | 127 Thousand USD | -85580.315% |
| Amarin Corporation plc | 165.54 Million USD | 34.268% |
| Mesoblast Limited | -9.81 Million USD | 1208.65% |
| Turnstone Biologics Corp. | 16.5 Million USD | -559.239% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 198.484% |
| Synaptogenix, Inc. | -6347.00 USD | 1714516.26% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 213460.784% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 32.567% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 93.809% |
| Better Therapeutics, Inc. | -2.72 Million USD | 4087.321% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 197.016% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 67.814% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 953939.411% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 1838.243% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 9920.758% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -1386.936% |
| Insmed Incorporated | 239.63 Million USD | 54.592% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -2941.196% |
| OmniAb, Inc. | 14.66 Million USD | -641.897% |
| Alector, Inc. | -95.05 Million USD | 214.477% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 13.379% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 350.36% |
| Zai Lab Limited | 170.9 Million USD | 36.33% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -32.899% |
| Aura Biosciences, Inc. | -1.29 Million USD | 8502.625% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -83603.077% |
| Immunic, Inc. | -111 Thousand USD | 98130.631% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -586.35% |
| Veracyte, Inc. | 248.14 Million USD | 56.15% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 101.557% |
| FibroGen, Inc. | 128.9 Million USD | 15.585% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 19293362.411% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 1032.674% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 96.798% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -27872.751% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 69.378% |
| TG Therapeutics, Inc. | 219.1 Million USD | 50.338% |
| Galecto, Inc. | -830 Thousand USD | 13210.12% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 7956.606% |
| Fortrea Holdings Inc. | 424 Million USD | 74.336% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 226.283% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 19291.182% |
| XBiotech Inc. | -1.74 Million USD | 6339.335% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 9920.758% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 334.155% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 244.06% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -48.242% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -547.587% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 72.03% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 319.175% |
| Vaxxinity, Inc. | -2.23 Million USD | 4970.815% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 66.698% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 1060.928% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -345.029% |
| NexImmune, Inc. | -1.02 Million USD | 10716.29% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -2014974.074% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 1631.372% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 99.037% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 162929.395% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 3164.32% |
| Ainos, Inc. | -253.73 Thousand USD | 42985.238% |
| Pluri Inc. | 322 Thousand USD | -33693.168% |
| Prothena Corporation plc | -129.2 Million USD | 184.221% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -115.798% |
| Celularity Inc. | 6.75 Million USD | -1510.866% |
| Rallybio Corporation | -150 Thousand USD | 72642.667% |
| Cue Biopharma, Inc. | -32.6 Million USD | 433.714% |
| MeiraGTx Holdings plc | 287 Thousand USD | -37814.286% |
| Omeros Corporation | -69.77 Million USD | 255.941% |
| Humacyte, Inc. | -76.55 Million USD | 242.148% |
| Immunocore Holdings plc | 248.39 Million USD | 56.192% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 817.345% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -74.432% |
| Blueprint Medicines Corporation | 236.58 Million USD | 54.006% |
| CalciMedica, Inc. | -58 Thousand USD | 187710.345% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 7730.715% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -274.51% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 3926.09% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 452.548% |
| Pulmatrix, Inc. | -8.22 Million USD | 1423.771% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 9400.342% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 27371.679% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 127.286% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -3820.399% |
| Cytokinetics, Incorporated | -322.59 Million USD | 133.731% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -12521.896% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 32010.264% |
| Vor Biopharma Inc. | -3.49 Million USD | 3216.094% |
| Roivant Sciences Ltd. | 109.23 Million USD | 0.385% |
| Evogene Ltd. | 1.39 Million USD | -7677.984% |
| ProKidney Corp. | -3.16 Million USD | 3533.701% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 347.8% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -1486.904% |
| CorMedix Inc. | -205.56 Thousand USD | 53034.881% |
| BioLineRx Ltd. | 1.1 Million USD | -9720.758% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 238.315% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 329839.394% |
| Atai Life Sciences N.V. | -5000.00 USD | 2176380.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 89395.005% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 113447.917% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 7933.981% |
| Sagimet Biosciences Inc. | 2 Million USD | -5340.7% |
| MediciNova, Inc. | 979.7 Thousand USD | -11006.813% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 229.05% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 115180.112% |
| GeoVax Labs, Inc. | -20.72 Million USD | 625.145% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 55.502% |
| Biomea Fusion, Inc. | -4.2 Million USD | 2690.193% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 87.526% |
| Mereo BioPharma Group plc | 7.42 Million USD | -1365.311% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 35201.29% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 906883.333% |
| Absci Corporation | -41.84 Million USD | 360.016% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 2176380.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 242.477% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 4521.536% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 49.089% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 11663.656% |
| Allakos Inc. | -6.14 Million USD | 1871.926% |
| Imunon, Inc. | -720 Thousand USD | 15212.951% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 257.711% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 77.135% |
| BioAtla, Inc. | -103.73 Million USD | 204.9% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 953939.411% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 61231.461% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 144.813% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 35088.424% |
| XOMA Corporation | 3.86 Million USD | -2718.285% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 255.26% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -635.528% |
| aTyr Pharma, Inc. | -2.38 Million USD | 4656.7% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -773.307% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 375320.69% |
| Viridian Therapeutics, Inc. | -1 Million USD | 10895.04% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -837030669.231% |
| Akari Therapeutics, Plc | -4000.00 USD | 2720450.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 82.915% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -55785.737% |
| UroGen Pharma Ltd. | 73.35 Million USD | -48.345% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 507.635% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -937143.755% |
| Orgenesis Inc. | -5.72 Million USD | 2000.681% |
| Entera Bio Ltd. | -56 Thousand USD | 194410.714% |
| GH Research PLC | -315 Thousand USD | 34644.127% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 57673.545% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 20826.476% |
| Xencor, Inc. | -85.26 Million USD | 227.626% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 49342.229% |
| Replimune Group, Inc. | -2.65 Million USD | 4198.456% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 10967.967% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 38.815% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -55785.737% |
| Portage Biotech Inc. | -54 Thousand USD | 201607.407% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 115180.112% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 28963.13% |
| OncoCyte Corporation | 413 Thousand USD | -26247.215% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 2420878.643% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 49015415.315% |
| Purple Biotech Ltd. | -196 Thousand USD | 55617.347% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -1113.359% |
| scPharmaceuticals Inc. | 9.78 Million USD | -1012.39% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 1141.785% |
| HilleVax, Inc. | -2.15 Million USD | 5147.032% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 112279.381% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 725333.271% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 16389.521% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 473204.348% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 1449762.677% |
| Savara Inc. | -44.26 Million USD | 345.841% |
| Curis, Inc. | 9.81 Million USD | -1009.102% |
| Daré Bioscience, Inc. | 2.76 Million USD | -3828.981% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 87299.09% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 6393.464% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 47825.439% |
| BeiGene, Ltd. | 2.07 Billion USD | 94.766% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 3991.913% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 127.226% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -91.952% |
| Erasca, Inc. | -3.73 Million USD | 3015.702% |
| bluebird bio, Inc. | -4.03 Million USD | 2800.099% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 385719.108% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 94.286% |
| DBV Technologies S.A. | 15.72 Million USD | -591.849% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 385719.108% |
| Moderna, Inc. | 2.15 Billion USD | 94.951% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 11992.24% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -1259.156% |
| Molecular Templates, Inc. | 50.39 Million USD | -115.922% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 20401.119% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 18.667% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 1848.859% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 376.578% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 197.918% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 3132.72% |
| MacroGenics, Inc. | 50.52 Million USD | -115.358% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 1884.421% |
| Prime Medicine, Inc. | -147.9 Million USD | 173.57% |
| Aditxt, Inc. | -111.66 Thousand USD | 97551.191% |
| Adagene Inc. | 18.11 Million USD | -500.801% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -22197.951% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 22.388% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 31.059% |
| SciSparc Ltd. | 2.19 Million USD | -4855.1% |
| Vericel Corporation | 135.57 Million USD | 19.739% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 434504.567% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 351316.836% |
| Generation Bio Co. | -73.91 Million USD | 247.223% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 25000.229% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -99.224% |
| Invivyd, Inc. | -2.02 Million USD | 5465.582% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 136.17% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 105297.316% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -12.915% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -10.709% |
| ADMA Biologics, Inc. | 88.21 Million USD | -23.347% |
| Clene Inc. | 533 Thousand USD | -20315.385% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -351.338% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 11470.324% |
| GeoVax Labs, Inc. | -20.72 Million USD | 625.145% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -5373.541% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 56098.477% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -118.48% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 1634.32% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 13116.029% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -30.449% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -148731.929% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -104.684% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 162.83% |
| Trevena, Inc. | 1.45 Million USD | -7378.625% |
| Surrozen, Inc. | -27.23 Million USD | 499.611% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 30925.496% |
| Cingulate Inc. | -582.91 Thousand USD | 18767.12% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 351112.903% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 652.383% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 1437537.252% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 12451.192% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 84.015% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 11113.563% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 193231.234% |
| Kronos Bio, Inc. | 1.37 Million USD | -7831.05% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 302.762% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 37365.068% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 22383.613% |
| ImmunityBio, Inc. | -17.89 Million USD | 708.239% |
| Korro Bio, Inc. | -3.63 Million USD | 3097.631% |
| Kineta, Inc. | 5.43 Million USD | -1902.835% |
| BioVie Inc. | -229.37 Thousand USD | 47538.932% |
| Codexis, Inc. | 57.33 Million USD | -89.79% |
| Celularity Inc. | 6.75 Million USD | -1510.866% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -2611.538% |
| Celcuity Inc. | -142.77 Thousand USD | 76315.224% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -214989.939% |
| Cibus, Inc. | 1.42 Million USD | -7552.18% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 29194.652% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 574.776% |
| IN8bio, Inc. | -2.5 Million USD | 4450.82% |
| Kodiak Sciences Inc. | -25.94 Million USD | 519.37% |
| Annexon, Inc. | -3.26 Million USD | 3430.701% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 5423.581% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 360.714% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -16902.188% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 86.023% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 37.085% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 5827.053% |
| Arcellx, Inc. | 108.27 Million USD | -0.494% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 436.167% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -37.384% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 614.438% |
| Moolec Science SA | -143.3 Thousand USD | 76031.754% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 357.134% |
| Geron Corporation | -123.5 Million USD | 188.106% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -3210.435% |
| Royalty Pharma plc | 1.79 Billion USD | 93.934% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 255.249% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 3012669.214% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -46926.03% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 197.666% |
| Humacyte, Inc. | -76.55 Million USD | 242.148% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 11564.073% |
| 89bio, Inc. | -273 Thousand USD | 39958.608% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 8756.643% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 12931.84% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 88566.667% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -9624.218% |
| Notable Labs, Ltd. | 113 Thousand USD | -96195.575% |
| Liquidia Corporation | 14.6 Million USD | -645.301% |
| Mustang Bio, Inc. | -2.22 Million USD | 4990.517% |
| Immunovant, Inc. | -231 Thousand USD | 47205.628% |
| Quantum-Si incorporated | 488 Thousand USD | -22197.951% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 295.853% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 362813.333% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -5743.931% |
| Acasti Pharma Inc. | -11 Thousand USD | 989318.182% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 53279.355% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 16880.527% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 164.959% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -9490.686% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 28660.105% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 5657.406% |
| PepGen Inc. | -1.18 Million USD | 9290.372% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 85780.315% |
| United Therapeutics Corporation | 2.07 Billion USD | 94.743% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 575.233% |
| Solid Biosciences Inc. | -76.56 Million USD | 242.123% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 131863.196% |
| Immuneering Corporation | -764.13 Thousand USD | 14340.098% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -164112.846% |
| Belite Bio, Inc | -399 Thousand USD | 27371.679% |
| XOMA Corporation | 3.86 Million USD | -2718.285% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 643.092% |
| Bionomics Limited | -434.44 Thousand USD | 25146.438% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 10231.657% |
| uniQure N.V. | 2.21 Million USD | -4812.596% |
| Cassava Sciences, Inc. | -89.42 Million USD | 221.685% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 218.187% |
| Forte Biosciences, Inc. | -9000.00 USD | 1209144.444% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 13131.617% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 25000.229% |
| Altimmune, Inc. | -65.37 Million USD | 266.451% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 69.943% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 10231.657% |
| Compugen Ltd. | 31.45 Million USD | -245.935% |
| Peak Bio, Inc. | 367.76 Thousand USD | -29487.594% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -343.849% |
| Benitec Biopharma Inc. | 108 Thousand USD | -100653.704% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 139605.128% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 9145.22% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 6072.228% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 91540.336% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 9145.22% |
| Instil Bio, Inc. | -4.75 Million USD | 2387.931% |
| argenx SE | 1.1 Billion USD | 90.184% |
| Immunome, Inc. | -8.9 Million USD | 1321.668% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 5857.354% |
| Verona Pharma plc | -679.62 Thousand USD | 16110.912% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 62279.429% |
| Shattuck Labs, Inc. | -2.38 Million USD | 4662.432% |
| CervoMed Inc. | -1.29 Million USD | 8511.544% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 4620.731% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 2377.873% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -4303.642% |
| Moolec Science SA | -143.3 Thousand USD | 76031.754% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 26768.137% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 4173.1% |
| AnaptysBio, Inc. | 14.78 Million USD | -636.175% |
| Design Therapeutics, Inc. | -537 Thousand USD | 20363.315% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 25583.372% |
| NeurAxis, Inc. | 2.15 Million USD | -4945.384% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -4970.55% |
| Lumos Pharma, Inc. | 2 Million USD | -5321.724% |
| Achilles Therapeutics plc | -4.73 Million USD | 2399.891% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 62279.429% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 103070.428% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -243.709% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -12521.896% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 10643.992% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 338.9% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -252955.814% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 13337.713% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 827079.784% |
| Palisade Bio, Inc. | 246 Thousand USD | -44133.333% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 329839.394% |
| Beam Therapeutics Inc. | -59.67 Million USD | 282.354% |
| Neurogene Inc. | -3.26 Million USD | 3435.806% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 21.905% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 3047.291% |
| Sesen Bio, Inc. | 40 Million USD | -172.035% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 36737.71% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 2802.086% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 1237.508% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -672.827% |
| Athira Pharma, Inc. | -969 Thousand USD | 11329.515% |
| Vaccinex, Inc. | -16 Million USD | 779.918% |
| HCW Biologics Inc. | -574.82 Thousand USD | 19029.968% |
| XOMA Corporation | 3.86 Million USD | -2718.285% |
| Nektar Therapeutics | 53.47 Million USD | -103.474% |
| Arvinas, Inc. | 71.8 Million USD | -51.552% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 230.377% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 273.34% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 33893.168% |
| Rezolute, Inc. | -36 Thousand USD | 302361.111% |
| Clene Inc. | 533 Thousand USD | -20315.385% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 8474710.592% |
| BeyondSpring Inc. | 1.75 Million USD | -6114.392% |
| Synlogic, Inc. | -1.92 Million USD | 5755.613% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 294191.892% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 1818.478% |
| Peak Bio, Inc. | 367.76 Thousand USD | -29487.594% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 673.823% |
| Krystal Biotech, Inc. | 47.6 Million USD | -128.577% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 22.877% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -2065.453% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 4302.58% |
| MannKind Corporation | 136.19 Million USD | 20.102% |
| Ikena Oncology, Inc. | -50.49 Million USD | 315.507% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gossamer Bio, Inc. | -4.38 Million USD | 2581.505% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 43280.159% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 2176380.0% |
| Legend Biotech Corporation | 140.92 Million USD | 22.788% |
| Mural Oncology plc | -2.56 Million USD | 4338.956% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 19848.457% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 108914.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -424.304% |
| REGENXBIO Inc. | 53.02 Million USD | -105.197% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 2131.267% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 56663.483% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 6382.564% |
| Vaxart, Inc. | -60.76 Million USD | 279.079% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 41508.783% |
| Cellectis S.A. | 18 Thousand USD | -604422.222% |
| Longeveron Inc. | 221 Thousand USD | -49137.104% |
| Repare Therapeutics Inc. | -80.07 Million USD | 235.899% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 90.044% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 8509.119% |
| Revolution Medicines, Inc. | -399.66 Million USD | 127.226% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 310997.143% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -221969.388% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 98.736% |
| Denali Therapeutics Inc. | -93.34 Million USD | 216.572% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 434504.567% |
| Veru Inc. | 7.56 Million USD | -1338.211% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 72162.252% |
| Cingulate Inc. | -582.91 Thousand USD | 18767.12% |
| Passage Bio, Inc. | -3.72 Million USD | 3024.321% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 903570.608% |
| Exicure, Inc. | -1.42 Million USD | 7746.803% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 28510.966% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -3925.675% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 21324.753% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -59.725% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 72833.228% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 283.789% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -27729.668% |
| OmniAb, Inc. | 14.66 Million USD | -641.897% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -444.26% |
| Lipocine Inc. | -2.85 Million USD | 3916.94% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 6004.178% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 2007.344% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 7323.969% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -44.477% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 167506.154% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -29.086% |
| Ocugen, Inc. | -33.53 Million USD | 424.46% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 3541.303% |
| Q32 Bio Inc. | 578 Thousand USD | -18725.952% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 41161.887% |
| Alumis Inc. Common Stock | -1.28 Million USD | 8574.611% |
| Equillium, Inc. | 35.95 Million USD | -202.614% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 6474.575% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -21633.286% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 2632272.23% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 42113.127% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -25641.876% |
| Dominari Holdings Inc. | 2.03 Million USD | -5236.636% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 59408.556% |
| vTv Therapeutics Inc. | -13.59 Million USD | 900.397% |
| Bio-Techne Corporation | 773.07 Million USD | 85.925% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -528.293% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 76.385% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 9408.298% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 553.77% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -830.273% |
| Nkarta, Inc. | -5.86 Million USD | 1954.047% |
| BioCardia, Inc. | -7.24 Million USD | 1601.09% |
| Iterum Therapeutics plc | -1.75 Million USD | 6317.943% |